ArticleVaccines2024

Effectiveness and Safety of the MVA-BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc).

Soowoo Back et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.